Frontlight ResearchEarly access
Antiphospholipid syndrome trials in Japan
2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Bunkyo-ku, Hamamatsu, Himeji, Isehara, Kodaira, Okayama, Ōta-ku, Sakai, Sapporo, Sendai, Suita, Toyama
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - Phase 1Enrolling by invitationPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Bunkyo-ku, Fukuoka, Hamamatsu, Himeji, Isehara, Kawachi-Nagano, Kodaira, Meguro-Ku, Okayama, Ōta-ku, Sakai, Sapporo, Sendai, Suita, Toyama
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106